|
1
|
Dolai S, Pal S, Yadav RK and Adak S:
Endoplasmic reticulum stress-induced apoptosis in Leishmania
through Ca2+-dependent and caspase-independent
mechanism. J Biol Chem. 286:13638–13646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elbein AD: Inhibitors of the biosynthesis
and processing of N-linked oligosaccharide chains. Annu Rev
Biochem. 56:497–534. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delom F, Fessart D and Chevet E:
Regulation of calnexin sub-cellular localization modulates
endoplasmic reticulum stress-induced apoptosis in MCF-7 cells.
Apoptosis. 12:293–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dricu A, Carlberg M, Wang M and Larsson O:
Inhibition of N-linked glycosylation using tunicamycin causes cell
death in malignant cells: role of down-regulation of the
insulin-like growth factor 1 receptor in induction of apoptosis.
Cancer Res. 57:543–548. 1997.PubMed/NCBI
|
|
5
|
Hitomi J, Katayama T, Taniguchi M, Honda
A, Imaizumi K and Tohyama M: Apoptosis induced by endoplasmic
reticulum stress depends on activation of caspase-3 via caspase-12.
Neurosci Lett. 357:127–130. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakagawa T, Zhu H, Morishima N, et al:
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and
cytotoxicity by amyloid-β. Nature. 403:98–103. 2000.PubMed/NCBI
|
|
7
|
Yu Q and Stamenkovic I: Localization of
matrix metalloproteinase 9 to the cell surface provides a mechanism
for CD44-mediated tumor invasion. Genes Dev. 13:35–48. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arch R, Wirth K, Hofmann M, et al:
Participation in normal immune responses of a metastasis-inducing
splice variant of CD44. Science. 257:682–685. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Desai B, Ma T, Zhu J and Chellaiah MA:
Characterization of the expression of variant and standard CD44 in
prostate cancer cells: identification of the possible molecular
mech+anism of CD44/MMP9 complex formation on the cell surface. J
Cell Biochem. 108:272–284. 2009.PubMed/NCBI
|
|
10
|
Naor D, Sionov RV and Ish-Shalom D: CD44:
structure, function, and association with the malignant process.
Adv Cancer Res. 71:241–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamane N, Tsujitani S, Makino M, Maeta M
and Kaibara N: Soluble CD44 variant 6 as a prognostic indicator in
patients with colorectal cancer. Oncology. 56:232–238. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wielenga VJ, Heider KH, Offerhaus GJ, et
al: Expression of CD44 variant proteins in human colorectal cancer
is related to tumor progression. Cancer Res. 53:4754–4756.
1993.PubMed/NCBI
|
|
13
|
Jung T, Gross W and Zoller M: CD44v6
coordinates tumor matrix-triggered motility and apoptosis
resistance. J Biol Chem. 286:15862–15874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mielgo A, van Driel M, Bloem A, Landmann L
and Gunthert U: A novel antiapoptotic mechanism based on
interference of Fas signaling by CD44 variant isoforms. Cell Death
Differ. 13:465–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fini ME and Girard MT: The pattern of
metalloproteinase expression by corneal fibroblasts is altered by
passage in cell culture. J Cell Sci. 97:373–383. 1990.PubMed/NCBI
|
|
16
|
Girard MT, Matsubara M, Kublin C, Tessier
MJ, Cintron C and Fini ME: Stromal fibroblasts synthesize
collagenase and stromelysin during long-term tissue remodeling. J
Cell Sci. 104:1001–1011. 1993.PubMed/NCBI
|
|
17
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smith KM, Gaultier A, Cousin H, Alfandari
D, White JM and DeSimone DW: The cysteine-rich domain regulates
ADAM protease function in vivo. J Cell Biol. 159:893–902. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anderegg U, Eichenberg T, Parthaune T, et
al: ADAM10 is the constitutive functional sheddase of CD44 in human
melanoma cells. J Invest Dermatol. 129:1471–1482. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huh MI, Lee YM, Seo SK, et al: Roles of
MMP/TIMP in regulating matrix swelling and cell migration during
chick corneal development. J Cell Biochem. 101:1222–1237. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagano O, Murakami D, Hartmann D, et al:
Cell-matrix interaction via CD44 is independently regulated by
different metalloproteinases activated in response to extracellular
Ca(2+) influx and PKC activation. J Cell Biol. 165:893–902.
2004.PubMed/NCBI
|
|
23
|
Pacheco-Rodriguez G, Steagall WK, Crooks
DM, et al: TSC2 loss in lymphangioleiomyomatosis cells correlated
with expression of CD44v6, a molecular determinant of metastasis.
Cancer Res. 67:10573–10581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dreier R, Grassel S, Fuchs S, Schaumburger
J and Bruckner P: Pro-MMP-9 is a specific macrophage product and is
activated by osteoarthritic chondrocytes via MMP-3 or a
MT1-MMP/MMP-13 cascade. Exp Cell Res. 297:303–312. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hernandez Rios M, Sorsa T, Obregon F, et
al: Proteolytic roles of matrix metalloproteinase (MMP)-13 during
progression of chronic periodontitis: initial evidence for
MMP-13/MMP-9 activation cascade. J Clin Periodontol. 36:1011–1017.
2009.PubMed/NCBI
|
|
26
|
Lazebnik YA, Kaufmann SH, Desnoyers S,
Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase
by a proteinase with properties like ICE. Nature. 371:346–347.
1994. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferreira KS, Kreutz C, Macnelly S, et al:
Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas
signaling in primary mouse hepatocytes. Apoptosis. 17:503–515.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ponta H, Sleeman J, Dall P, Moll J,
Sherman L and Herrlich P: CD44 isoforms in metastatic cancer.
Invasion Metastasis. 14:82–86. 1994.PubMed/NCBI
|
|
30
|
Spessotto P, Rossi FM, Degan M, et al:
Hyaluronan-CD44 interaction hampers migration of osteoclast-like
cells by down-regulating MMP-9. J Cell Biol. 158:1133–1144. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Samanna V, Ma T, Mak TW, Rogers M and
Chellaiah MA: Actin polymerization modulates CD44 surface
expression, MMP-9 activation, and osteoclast function. J Cell
Physiol. 213:710–720. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seipel D, Oliveira BC, Resende TL, et al:
Toxoplasma gondii infection positively modulates the macrophages
migratory molecular complex by increasing matrix
metalloproteinases, CD44 and alpha v beta 3 integrin. Vet
Parasitol. 169:312–319. 2010. View Article : Google Scholar
|
|
33
|
Chetty C, Vanamala SK, Gondi CS, Dinh DH,
Gujrati M and Rao JS: MMP-9 induces CD44 cleavage and CD44 mediated
cell migration in glioblastoma xenograft cells. Cell Signal.
24:549–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ponta H, Sherman L and Herrlich PA: CD44:
from adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morrison H, Sherman LS, Legg J, et al: The
NF2 tumor suppressor gene product, merlin, mediates contact
inhibition of growth through interactions with CD44. Genes Dev.
15:968–980. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wittig BM, Johansson B, Zoller M,
Schwarzler C and Gunthert U: Abrogation of experimental colitis
correlates with increased apoptosis in mice deficient for CD44
variant exon 7 (CD44v7). J Exp Med. 191:2053–2064. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lesley J, English N, Perschl A, Gregoroff
J and Hyman R: Variant cell lines selected for alterations in the
function of the hyaluronan receptor CD44 show differences in
glycosylation. J Exp Med. 182:431–437. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sleeman J, Rudy W, Hofmann M, Moll J,
Herrlich P and Ponta H: Regulated clustering of variant CD44
proteins increases their hyaluronate binding capacity. J Cell Biol.
135:1139–1150. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stevens JW, Palechek PL, Griebling TL,
Midura RJ, Rokhlin OW and Cohen MB: Expression of CD44 isoforms in
human prostate tumor cell lines. Prostate. 28:153–161. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu Q, Toole BP and Stamenkovic I:
Induction of apoptosis of metastatic mammary carcinoma cells in
vivo by disruption of tumor cell surface CD44 function. J Exp Med.
186:1985–1996. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Isacke CM and Yarwood H: The hyaluronan
receptor, CD44. Int J Biochem Cell Biol. 34:718–721. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kobayashi T: Suppression of matrix
metalloproteinase-9 expression in undifferentiated, non-apoptotic
keratinocytes is abrogated by the cleavage of poly(ADP-ribose)
polymerase-1. Apoptosis. 16:1205–1216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu Q and Stamenkovic I: Transforming
growth factor-beta facilitates breast carcinoma metastasis by
promoting tumor cell survival. Clin Exp Metastasis. 21:235–242.
2004. View Article : Google Scholar : PubMed/NCBI
|
